Linked Life Data

19271151

Source:http://linkedlifedata.com/resource/pubmed/id/19271151

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-7-17
pubmed:abstractText
Azithromycin (AZM) has been used as an anti-inflammatory agent in the treatment of cystic fibrosis (CF), particularly those with chronic infection with P. aeruginosa (PA). To investigate mechanisms associated with the beneficial effects of AZM in CF, we examined bacterial load, cytokine levels, and clearance of inflammatory cells in CF mice infected with mucoid PA and treated with AZM.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1420-908X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
491-501
pubmed:meshHeading
pubmed-meshheading:19271151-Alginates, pubmed-meshheading:19271151-Animals, pubmed-meshheading:19271151-Anti-Bacterial Agents, pubmed-meshheading:19271151-Apoptosis, pubmed-meshheading:19271151-Azithromycin, pubmed-meshheading:19271151-Biofilms, pubmed-meshheading:19271151-Bronchoalveolar Lavage Fluid, pubmed-meshheading:19271151-Cystic Fibrosis, pubmed-meshheading:19271151-Cytokines, pubmed-meshheading:19271151-Drug Resistance, Bacterial, pubmed-meshheading:19271151-Female, pubmed-meshheading:19271151-Lung, pubmed-meshheading:19271151-Mice, pubmed-meshheading:19271151-Neutrophils, pubmed-meshheading:19271151-Peroxidase, pubmed-meshheading:19271151-Pneumonia, pubmed-meshheading:19271151-Pseudomonas Infections, pubmed-meshheading:19271151-Respiratory Mucosa, pubmed-meshheading:19271151-Survival Analysis
pubmed:year
2009
pubmed:articleTitle
Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice.
pubmed:affiliation
Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI 48105, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't